Issy les Moulineaux, France

Thierry Fontaine


Average Co-Inventor Count = 4.2

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Issy les Moulineaux, FR (1999 - 2006)
  • Clamart, FR (2012)

Company Filing History:


Years Active: 1999-2012

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Thierry Fontaine

Introduction

Thierry Fontaine is a notable inventor based in Issy les Moulineaux, France. He has made significant contributions to the field of biotechnology, particularly in the development of immunogenic compositions and antifungal molecules. With a total of 5 patents, Fontaine's work has had a considerable impact on medical research and applications.

Latest Patents

Fontaine's latest patents include a purified polypeptide that comprises a C-terminus Merozoite Surface Protein 1 (MSP1) antigen, which carries a Glycosyl-phosphatidyl-inositol group (GPI). This invention is crucial for developing a vaccine against specific infections. Another significant patent involves a method for sorting antifungal molecules that act on glucanosyltransferase activity. This invention discloses proteins with β (1–3) glucanosyltransferase type activities, which can be utilized to detect the antifungal activity of various molecules.

Career Highlights

Throughout his career, Thierry Fontaine has worked with prestigious institutions, including the Institut Pasteur. His research has focused on innovative solutions to combat infections and improve health outcomes. His contributions have been recognized within the scientific community, establishing him as a leading figure in his field.

Collaborations

Fontaine has collaborated with notable colleagues such as Robbert Hartland and Isabelle Mouyna. These partnerships have further enhanced his research capabilities and expanded the impact of his inventions.

Conclusion

Thierry Fontaine's innovative work in biotechnology and his numerous patents highlight his dedication to advancing medical science. His contributions continue to influence the development of effective treatments and vaccines.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…